After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Health Information Services industry segment, falling under the Healthcare sector. The current market capitalization of 10x Genomics Inc is $1.46B. A total of 3.07 million shares were traded on the day, compared to an average of 3.15M shares.
In the most recent transaction, Saxonov Serge sold 9,348 shares of TXG for 13.79 per share on Aug 22 ’25. After the transaction, the Chief Executive Officer now owns 945,892 company shares. In a previous transaction on Aug 22 ’25, Taich Adam sold 22,315 shares at 13.79 per share. TXG shares that Chief Financial Officer owns now total 309,273.
Among the insiders who sold shares, Hindson Benjamin J. disposed of 7,486 shares on Aug 22 ’25 at a per-share price of $13.79. This resulted in the insider holding 440,888 shares of TXG after the transaction. In another insider transaction, Saxonov Serge bought 9,228 shares at $13.41 per share on Aug 22 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, TXG has a high of $23.07 and a low of $6.78.
As of this writing, TXG has an earnings estimate of -$0.07 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.07 per share and a lower estimate of -$0.07. The company reported an EPS of -$0.02 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. TXG’s latest balance sheet shows that the firm has $587.45M in Cash & Short Term Investments as of fiscal 2021. There were $81.98M in debt and $110.36M in liabilities at the time. Its Book Value Per Share was $6.21, while its Total Shareholder’s Equity was $817.57M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Buy with a score of 3.72.
